approval
saveTREMFYA (GUSELKUMAB) — FDA approval
community read0 votes
Sponsor: JANSSEN BIOTECH. Form: INJECTABLE. Route: INJECTION
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalTREMFYA (GUSELKUMAB) — FDA approvalSep 26, 2025 · 369d ago
- approvalTREMFYA (GUSELKUMAB) — FDA approvalSep 26, 2025 · 369d ago
- approvalTREMFYA (GUSELKUMAB) — FDA approvalSep 19, 2025 · 376d ago
- approvalTREMFYA (GUSELKUMAB) — FDA approvalJun 17, 2025 · 470d ago
- approvalTREMFYA (GUSELKUMAB) — FDA approvalMar 25, 2025 · 554d ago
- approvalTREMFYA (GUSELKUMAB) — FDA approvalMar 20, 2025 · 559d ago
- approvalTREMFYA (GUSELKUMAB) — FDA approvalSep 11, 2024 · 749d ago
- approvalTREMFYA (GUSELKUMAB) — FDA approvalJun 29, 2023 · 1189d ago
same company · ±60 days · 5
- approval(daratumumab + hyaluronidase (human recombinant)): DARZALEX FASPRO (DARATUMUMAB AND HYALURONIDASE-FIHJ) — FDA approvalMay 1, 2020
- approvalapalutamide: ERLEADA (APALUTAMIDE) — FDA approvalJul 10, 2020
- approvalguselkumab: TREMFYA (GUSELKUMAB) — FDA approvalJul 13, 2020
- approvalustekinumab: STELARA (USTEKINUMAB) — FDA approvalApr 7, 2020
- approvalerdafitinib: BALVERSA (ERDAFITINIB) — FDA approvalApr 2, 2020
comments(0)
5-min edit window · permanent after that